Generative protein design

Biotechnology & Synthetic BiologyUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

99 papers

Active filtersClassification:Supporting

Showing 13-24 of total 99 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Intelligent De novo Design of Multifunctional Taste Peptides via an integrated deep learning, conditional diffusion, and reinforcement learning platform.

Xiong H; Wang Y; Pu S; Shao G

2026PubMedSupporting evidence

Novel human neutralizing monoclonal antibodies against Pregnancy-Associated Plasma Protein A for the treatment of Autosomal Dominant Polycystic Kidney Disease.

Hu E; Gardener MJ; Wang X; Luo G; Kotzer C; Jiang L; Mallick E; Srinivasan A; Ouro-Gnao L; Firczuk H; Chandler S; Chung CW; Goswami P; Madi S; Lenhard S; Alsaid H; Doan M; Nanayakkara K; Swerdlow DI; Roberts J; Torres VE

Jan 1, 2026Kidney international

2026PubMedSupporting evidence

Low-temperature plasma technology: comprehensive applications in microalgae cultivation, mutagenesis, and downstream processing.

Xu W; Ikram S; Qin Z; Kader K; Peng Y; Liu Y; Wolfs N; Yang C; Hou C; Imam A; Liu Q; Zhang H; Cheng H; Chen L; Cheng H; Ren M

Jan 1, 2026Bioresource technology

2026PubMedSupporting evidence

Carbamylation as a Novel Marker of Coronary Artery Calcification in People With CKD: Findings from a Phenome-Wide Association Study in CRIC.

Awwad A; Garimella P; Rhee EP; Janowski J; Karumanchi SA; Nigwekar S; Allegretti AS; Berg AH; Lash JP; Gutiérrez-Sacristán A; Tang M; Kalim S

Jan 1, 2026American journal of kidney diseases : the official journal of the National Kidney Foundation

2026PubMedSupporting evidence

Deep learning-driven de novo discovery of binders targeting the transmembrane domain of BamA.

Du M; Xin Y; Xu B; Zhang Y; Han L; Ji B; Zhao J; Zhao Y

Jan 1, 2026Archives of microbiology

2026PubMedSupporting evidence

Beyond ER-Golgi trafficking: unconventional protein secretion as a new design frontier for synthetic secretion switches in mammalian cells.

Shi B; Qiu X; Jiang Y; Cai J; Zhu L

Jan 1, 2026Communications biology

2026PubMedSupporting evidence

Ursolic acid attenuates LPS-induced cognitive dysfunction through the modulation of oxidative stress, neuroinflammation, and hippocampal synaptic plasticity.

Choi GY; Lee S; Je AR; Choi H; Moon E; Cho E; Kwon SH; Lee KB; Kweon HS

Jan 1, 2026Phytomedicine : international journal of phytotherapy and phytopharmacology

2026PubMedSupporting evidence

DASH: A Pocket-Aware and Objective-Aware Framework for Million-Scale Structure-Based Molecular Generation.

Zhang B; Xu H; Wang X; Li L; Jin Z

Jan 1, 2026Journal of chemical information and modeling

2026PubMedSupporting evidence

Fibrosis: Bridging fundamental mechanisms to precision medicine via advanced therapeutics.

An L; Lin P; Chen K; Chen Y; Feng Y; Liu Z; Wang C

Jan 1, 2026Advanced drug delivery reviews

2026PubMedSupporting evidence

Efflux pump gene ABCA as targets for deep learning-based de novo inhibitors in invasive aspergillosis caused by Aspergillus fumigatus.

Ahmed NM; Ismail RSN; Suleiman AA

Jan 1, 2026Computational biology and chemistry

2026PubMedSupporting evidence

Harnessing the Power of Large Language Models for Drug Discovery: A Systematic Review of Current Applications and Future Directions.

Wal P; Shukla M; Sachan K; Wal A; Chellammal HSJ; Tiwari M; Gasmi A

Jan 1, 2026Current computer-aided drug design

2026PubMedSupporting evidence

Sampling protein language models for functional protein design.

Darmawan JT; Gal Y; Notin P

Jan 1, 2026Cell systems